Jane Street Group, LLC Adicet Bio, Inc. Transaction History

Jane Street Group, LLC

$384 Billion
Q1 2025

A detailed history of Jane Street Group, LLC transactions in Adicet Bio, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 16,299 shares of ACET stock, worth $12,224. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,299

Previous 16,299 -0.0%

Holding current value

$12,224

Previous $12,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$0.76 - $1.09 $3,030 - $4,345	3,987 Added 32.38%	16,299 $12,000
Q4 2024 Feb 14, 2025	SELL	$0.86 - $1.52 $53,711 - $94,931	-62,455 Reduced 83.53%	12,312 $11,000
Q3 2024 Nov 14, 2024	SELL	$1.07 - $1.63 $141,527 - $215,598	-132,269 Reduced 63.89%	74,767 $107,000
Q2 2024 Aug 14, 2024	BUY	$1.21 - $2.4 $179,619 - $356,270	148,446 Added 253.36%	207,036 $250,000
Q1 2024 May 15, 2024	BUY	$1.76 - $3.45 $62,617 - $122,744	35,578 Added 154.61%	58,590 $137,000
Q4 2023 Feb 14, 2024	BUY	$1.11 - $1.89 $25,543 - $43,492	23,012 New	23,012 $43,000
Q1 2023 May 15, 2023	BUY	$5.52 - $9.23 $772,960 - $1.29 Million	140,029 Added 833.31%	156,833 $903,000
Q4 2022 Feb 14, 2023	SELL	$7.72 - $21.27 $1.51 Million - $4.16 Million	-195,600 Reduced 92.09%	16,804 $150,000
Q3 2022 Nov 14, 2022	BUY	$13.43 - $18.74 $2.85 Million - $3.98 Million	212,404 New	212,404 $3.02 Million
Q2 2021 Aug 16, 2021	SELL	$9.19 - $15.93 $167,258 - $289,926	-18,200 Closed	0 $0
Q1 2021 May 18, 2021	BUY	$12.12 - $17.17 $220,584 - $312,494	18,200 New	18,200 $238,000

Others Institutions Holding ACET

# of Institutions

Shares Held

57.4M

Call Options Held

36.9K

Put Options Held

16.5K

View Full List

About Adicet Bio, Inc.

Ticker ACET
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,030,800
Market Cap $30M
Description
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...

More about ACET

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Adicet Bio, Inc. Transaction History